Edurant

Rilpivirine Hydrochloride

5.0 Moderate risk

Edurant & Pyelocaliectasis

15.4%

of users reported Pyelocaliectasis

53.8%

also reported Severe reaction

83.3%

are men

Most common medical consequences

Severe reaction
53.8%
Birth Defects
46.2%

Have you experienced any negative side effects from this medication?

Edurant: general information

Most common side effects (11)

Most commonly affected ages

20 - 29 years
6.9%
30 - 39 years
6.9%
40 - 49 years
24.0%
50 - 59 years
49.1%
60 - 69 years
13.1%